Improved virus purification processes for vaccines and gene therapy

Piergiuseppe Nestola, Cristina Peixoto, Ricardo R J S Silva, Paula M. Alves, José P B Mota, Manuel J T Carrondo

Research output: Contribution to journalReview article

43 Citations (Scopus)

Abstract

The downstream processing of virus particles for vaccination or gene therapy is becoming a critical bottleneck as upstream titers keep improving. Moreover, the growing pressure to develop cost-efficient processes has brought forward new downstream trains. This review aims at analyzing the state-of-the-art in viral downstream purification processes, encompassing the classical unit operations and their recent developments. Emphasis is given to novel strategies for process intensification, such as continuous or semi-continuous systems based on multicolumn technology, opening up process efficiency. Process understanding in the light of the pharmaceutical quality by design (QbD) initiative is also discussed. Finally, an outlook of the upcoming breakthrough technologies is presented. Biotechnol. Bioeng. 2015;112: 843-857.

Original languageEnglish
Pages (from-to)843-857
Number of pages15
JournalBiotechnology and Bioengineering
Volume112
Issue number5
DOIs
Publication statusPublished - 1 May 2015

Fingerprint

Active Immunotherapy
Gene therapy
Vaccines
Viruses
Genetic Therapy
Purification
Technology
Virion
Drug products
Vaccination
Pressure
Costs and Cost Analysis
Processing
Pharmaceutical Preparations
Costs

Keywords

  • Continuous purification
  • Downstream bioprocessing
  • Gene therapy
  • Process intensification
  • Vaccines

Cite this

@article{1f5f4b7133924eeea167cd210651068e,
title = "Improved virus purification processes for vaccines and gene therapy",
abstract = "The downstream processing of virus particles for vaccination or gene therapy is becoming a critical bottleneck as upstream titers keep improving. Moreover, the growing pressure to develop cost-efficient processes has brought forward new downstream trains. This review aims at analyzing the state-of-the-art in viral downstream purification processes, encompassing the classical unit operations and their recent developments. Emphasis is given to novel strategies for process intensification, such as continuous or semi-continuous systems based on multicolumn technology, opening up process efficiency. Process understanding in the light of the pharmaceutical quality by design (QbD) initiative is also discussed. Finally, an outlook of the upcoming breakthrough technologies is presented. Biotechnol. Bioeng. 2015;112: 843-857.",
keywords = "Continuous purification, Downstream bioprocessing, Gene therapy, Process intensification, Vaccines",
author = "Piergiuseppe Nestola and Cristina Peixoto and Silva, {Ricardo R J S} and Alves, {Paula M.} and Mota, {Jos{\'e} P B} and Carrondo, {Manuel J T}",
year = "2015",
month = "5",
day = "1",
doi = "10.1002/bit.25545",
language = "English",
volume = "112",
pages = "843--857",
journal = "Biotechnology and Bioengineering",
issn = "0006-3592",
publisher = "WILEY-BLACKWELL",
number = "5",

}

Improved virus purification processes for vaccines and gene therapy. / Nestola, Piergiuseppe; Peixoto, Cristina; Silva, Ricardo R J S; Alves, Paula M.; Mota, José P B; Carrondo, Manuel J T.

In: Biotechnology and Bioengineering, Vol. 112, No. 5, 01.05.2015, p. 843-857.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Improved virus purification processes for vaccines and gene therapy

AU - Nestola, Piergiuseppe

AU - Peixoto, Cristina

AU - Silva, Ricardo R J S

AU - Alves, Paula M.

AU - Mota, José P B

AU - Carrondo, Manuel J T

PY - 2015/5/1

Y1 - 2015/5/1

N2 - The downstream processing of virus particles for vaccination or gene therapy is becoming a critical bottleneck as upstream titers keep improving. Moreover, the growing pressure to develop cost-efficient processes has brought forward new downstream trains. This review aims at analyzing the state-of-the-art in viral downstream purification processes, encompassing the classical unit operations and their recent developments. Emphasis is given to novel strategies for process intensification, such as continuous or semi-continuous systems based on multicolumn technology, opening up process efficiency. Process understanding in the light of the pharmaceutical quality by design (QbD) initiative is also discussed. Finally, an outlook of the upcoming breakthrough technologies is presented. Biotechnol. Bioeng. 2015;112: 843-857.

AB - The downstream processing of virus particles for vaccination or gene therapy is becoming a critical bottleneck as upstream titers keep improving. Moreover, the growing pressure to develop cost-efficient processes has brought forward new downstream trains. This review aims at analyzing the state-of-the-art in viral downstream purification processes, encompassing the classical unit operations and their recent developments. Emphasis is given to novel strategies for process intensification, such as continuous or semi-continuous systems based on multicolumn technology, opening up process efficiency. Process understanding in the light of the pharmaceutical quality by design (QbD) initiative is also discussed. Finally, an outlook of the upcoming breakthrough technologies is presented. Biotechnol. Bioeng. 2015;112: 843-857.

KW - Continuous purification

KW - Downstream bioprocessing

KW - Gene therapy

KW - Process intensification

KW - Vaccines

UR - http://www.scopus.com/inward/record.url?scp=84925689348&partnerID=8YFLogxK

U2 - 10.1002/bit.25545

DO - 10.1002/bit.25545

M3 - Review article

VL - 112

SP - 843

EP - 857

JO - Biotechnology and Bioengineering

JF - Biotechnology and Bioengineering

SN - 0006-3592

IS - 5

ER -